Concert Pharmaceuticals, Inc. financial data

Industry
Pharmaceutical Preparations
Location
65 Hayden Avenue, Suite 3000 N, Lexington, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2022 - Nov 7, 2022

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 902 % -31%
Debt-to-equity 42.8 % +83.1%
Return On Equity -112 % -97.8%
Return On Assets -78.7 % -70.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 47.9M shares +38.3%
Common Stock, Shares, Outstanding 47.9M shares +47.9%
Common Stock, Value, Issued 45K USD +45.2%
Weighted Average Number of Shares Outstanding, Basic 49.7M shares +45.9%
Weighted Average Number of Shares Outstanding, Diluted 49.7M shares +45.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 8K USD -98.5%
Research and Development Expense 103M USD +33.3%
General and Administrative Expense 21.6M USD +0.18%
Operating Income (Loss) -124M USD -88.1%
Net Income (Loss) Attributable to Parent -126M USD -90.5%
Earnings Per Share, Basic -3.24 USD/shares +25.6%
Earnings Per Share, Diluted -3.24 USD/shares +25.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 95.2M USD -8.18%
Marketable Securities, Current 675K USD -73.6%
Accounts Receivable, after Allowance for Credit Loss, Current 1.44M USD +203%
Assets, Current 157M USD +39.2%
Property, Plant and Equipment, Net 4.57M USD -16%
Operating Lease, Right-of-Use Asset 8.21M USD -5.55%
Other Assets, Noncurrent 0 USD -100%
Assets 171M USD +33.5%
Accounts Payable, Current 2.75M USD +370%
Employee-related Liabilities, Current 2.56M USD +6.74%
Liabilities, Current 17.4M USD +44.7%
Contract with Customer, Liability, Noncurrent 7.6M USD +176%
Operating Lease, Liability, Noncurrent 12.9M USD -9.46%
Liabilities 37.9M USD +30.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax -134K USD -76.3%
Retained Earnings (Accumulated Deficit) -440M USD -40.4%
Stockholders' Equity Attributable to Parent 133M USD +34.4%
Liabilities and Equity 171M USD +33.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -32.3M USD -56%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities -49.9M USD -263%
Common Stock, Shares Authorized 200M shares +100%
Common Stock, Shares, Issued 48.1M shares +47.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -82.3M USD -755%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 96.3M USD -8.09%
Payments to Acquire Property, Plant, and Equipment 92K USD 0%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -126M USD -90.2%
Operating Lease, Liability, Current 1.35M USD +22.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure 0%
Preferred Stock, Shares Authorized 5M shares 0%
Operating Lease, Payments 764K USD +2.97%
Additional Paid in Capital 573M USD +39%
Share-based Payment Arrangement, Expense 8.74M USD -31.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%